This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Mayo Foundation for Medical Education and Research, Vanderbilt University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Innovations by Ronald A. Karwoski
Introduction
Ronald A. Karwoski is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical imaging and diagnostics. His work focuses on developing systems and methods that enhance the classification of tissue masses, particularly in identifying malignancies.
Latest Patents
Karwoski holds a patent for a "System and method for tomography-based radiomic mass analysis." This innovative method classifies a tissue mass as either malignant or benign. The process involves identifying a region of interest in computed tomography (CT) imaging data, segmenting the data to delineate portions of the tissue mass, and extracting a set of radiomic parameters. These parameters may include the location, shape, surface characteristics, and texture distribution of the tissue mass. Ultimately, the method generates a report that classifies indeterminate lung nodules based on the extracted parameters.
Career Highlights
Throughout his career, Ronald A. Karwoski has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and Vanderbilt University. His experience in these institutions has allowed him to collaborate with leading experts in the field of medical research and imaging.
Collaborations
Some of his notable coworkers include Brian J. Bartholmai and Tobias Peikert. Their collaborative efforts have contributed to advancements in medical imaging technologies and improved diagnostic methods.
Conclusion
Ronald A. Karwoski's innovative work in tomography-based radiomic mass analysis exemplifies the impact of technology on medical diagnostics. His contributions continue to influence the field and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile